4-chloro-7-methoxyquinoline-6-carboxamide | CAS:417721-36-9

We serve 4-chloro-7-methoxyquinoline-6-carboxamide CAS:417721-36-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-chloro-7-methoxyquinoline-6-carboxamide

Chemical Name:4-chloro-7-methoxyquinoline-6-carboxamide
CAS.NO:417721-36-9
Synonyms:7-methoxy-4-chloro-quinoline-6-carboxamide
6-Quinolinecarboxamide,4-chloro-7-methoxy
Molecular Formula:C11H9ClN2O2
Molecular Weight:236.65400
 
Specification:
Appearance:White to yellow powder
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Lenvatinib
 
Note:The product under valid patents will not be offered to the countries covered by patents.



Contact us for information like 4-chloro-7-methoxyquinoline-6-carboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Quinolinecarboxamide,4-chloro-7-methoxy physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloro-7-methoxyquinoline-6-carboxamide Use and application,4-chloro-7-methoxyquinoline-6-carboxamide technical grade,usp/ep/jp grade.


Related News: How does the virus spread? The virus is thought to spread from person to person through respiratory droplets emitted by coughing or sneezing — but it’s not clear exactly when a person becomes contagious. There’s currently no evidence that the virus is airborne — meaning, for instance, it doesn’t travel across a large room.2-Amino-6-fluorobenzoic acid manufacturer A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.2-Bromo-5-fluoropyridine supplier South Korea and Japan are barring noncitizens who traveled recently to Hubei, the province at the center of the outbreak.1-Fluoro-2-nitrobenzene vendor In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.